BioLargo, Inc.
BLGO
$0.2365
$0.00351.50%
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -15.95% | -13.22% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -15.95% | -13.22% | |||
| Cost of Revenue | -27.46% | -8.62% | |||
| Gross Profit | 1.63% | -19.42% | |||
| SG&A Expenses | 23.36% | -12.94% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.57% | -8.33% | |||
| Operating Income | -52.31% | -19.21% | |||
| Income Before Tax | -63.40% | -35.90% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -63.40% | -35.90% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 37.28% | 54.28% | |||
| Net Income | -88.83% | -21.77% | |||
| EBIT | -52.31% | -19.21% | |||
| EBITDA | -54.81% | -19.20% | |||
| EPS Basic | -88.89% | -20.00% | |||
| Normalized Basic EPS | -140.00% | 28.57% | |||
| EPS Diluted | -88.89% | -20.00% | |||
| Normalized Diluted EPS | -140.00% | 28.57% | |||
| Average Basic Shares Outstanding | 0.24% | 1.37% | |||
| Average Diluted Shares Outstanding | 0.24% | 1.37% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||